IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,684,000 | -44.3% | 59,700 | -30.0% | 0.06% | -44.3% |
| Q4 2020 | $4,823,000 | +68.6% | 85,300 | +41.5% | 0.11% | +35.9% |
| Q3 2020 | $2,861,000 | -38.6% | 60,300 | -23.7% | 0.08% | -42.6% |
| Q2 2020 | $4,658,000 | +0.5% | 79,000 | -19.4% | 0.14% | -19.0% |
| Q1 2020 | $4,633,000 | +28.7% | 98,000 | +64.4% | 0.17% | +63.1% |
| Q4 2019 | $3,600,000 | +63.7% | 59,600 | +62.4% | 0.10% | +58.5% |
| Q3 2019 | $2,199,000 | -6.8% | 36,700 | 0.0% | 0.06% | -4.4% |
| Q2 2019 | $2,359,000 | +200.5% | 36,700 | +8.9% | 0.07% | +240.0% |
| Q2 2016 | $785,000 | +189.7% | 33,700 | +403.0% | 0.02% | +185.7% |
| Q1 2016 | $271,000 | – | 6,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |